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1. Lower body negative pressure provides a means to 
examine neurocirculatory reflexive responses to 
decreases in venous return to the heart. We assessed 
whether the pattern of catecholaminergic responses to 
lower body negative pressure depends on the intensity 
of the stimulus ( — 15 versus —40 mmHg).
2. In 14 healthy subjects, responses of forearm blood 
flow and noradrenaline spillover and of total body 
noradrenaline and adrenaline spillover were assessed 
during infusion of [3H]noradrenaline and [3H]adren- 
aline during —15 and —40 mmHg of lower body 
negative pressure.
3. During lower body negative pressure at
— 15 mmHg, heart rate and pulse pressure did not 
change, but forearm vascular resistance increased by 
25-50%. Forearm noradrenaline spillover increased
by about 50%, from 0.63 ±0.16 to 0.94 +  
0.23pmolm in 1 lOOml"' (P<0.05). Total body nor­
adrenaline spillover did not change, and total body 
adrenaline spillover increased significantly by about 
30%. Clearances of noradrenaline and adrenaline 
were unchanged.
4. During lower body negative pressure at
— 40 mmHg, heart rate increased and pulse pressure 
decreased. Forearm vascular resistance increased by 
about 100%, and forearm noradrenaline spillover 
increased by 80%, from 0.73 ±0.19 to 1.32 ±  
0.36 pmol min- l  100ml-1 (jP < 0.05). Total body nor­
adrenaline spillover increased by 30%, and total body 
adrenaline spillover increased by about 50%. Clear­
ances of both noradrenaline and adrenaline decreased.
5. The results are consistent with the view that 
selective deactivation of cardiopulmonary barorecep- 
tors during low-intensity lower body negative pressure 
increases sympathoneural traffic to forearm skeletal 
muscle and increases adrenomedullary secretion with­
out a concomitant generalized increase in sympatho­
neural outflows. Concurrent deactivation of cardiopul­
monary and arterial baroreceptors during high- 
intensity lower body negative pressure evokes a more 
generalized increase in sympathoneural activity, 
accompanied by further increased adrenomedullary 
secretion and decreased plasma clearances of norad­
renaline and adrenaline. The findings support differ­
ential increases in skeletal sympathoneural and adre­
nomedullary outflows during orthostasis, with more 
generalized sympathoneural responses to systemic 
hypotension.
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INTRODUCTION
The lower body negative pressure (LBNP) tech­
nique, introduced by Greenfield el al. [1] in 1963, 
has been used frequently for examination of cardio­
pulmonary baroreflex function. By applying different 
levels of subatmospheric pressure to the lower half 
of the body, one can study reflexive neurocircula­
tory responses to decreases in venous return to the 
heart. Results of the studies of Zoller et al. [2] and 
Johnson et al. [3] have led to the view that LBNP
tic outflows to skeletal muscle and skin. LBNP at 
intensities greater than —20 mmHg also deactivates 
arterial baroreceptors. Microneurographic studies 
have shown that both low- and high-intensity 
LBNPs increase efferent sympathoneural outflows 
to skeletal muscles in the arms and legs [4-6]. 
Because of differentiated autonomic response pat­
terns during different forms of stress, microneuro-
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graphic data about skeletal muscle and skin sym­
pathetic nerve activity may not detect alterations in 
sympathetic nerve activity in other organs.
Using a tracer approach, Baily et al. [7] reported 
increases in forearm noradrenaline (NA) spillover 
but not in ‘total’ body NA spillover (NA entry into 
arterial plasma) during low-intensity LBNP. Total 
body NA spillover responses to high-intensity 
LBNP have not been reported. Little is known 
about baroreflex regulation of adrenomedullary sec­
retion in humans during LBNP or orthostasis. One 
study reported an increase in venous plasma adre­
naline (AD) levels during low-intensity LBNP in 
humans [8]. The meaning of this finding is unclear, 
since venous plasma AD levels depend not only on 
adrenomedullary secretion but also on clearance of 
AD from arterial plasma and on local catechola­
mine removal in the forearm.
This study assessed the effects of low- and high- 
intensity LBNP on total body and forearm kinetics 
of NA and AD in healthy humans, using steady- 
state infusions of tracer amounts of [3H]NA and
[3H]AD [9].
MATERIALS AND METHODS 
Subjects
Fourteen healthy male subjects (aged 25-38 years) 
participated in the study after giving their written 
informed consent. The study protocol was approved 
by the hospital ethics committee. Before entry into 
the study, all participants had a normal physical 
examination. None suffered from cardiovascular or 
other major diseases, and they took no medication.
Study protocol
All subjects abstained from nicotine, alcohol, and 
caffeinated foods and beverages for at least 24 h 
before the study. The subjects were allowed to eat a 
light breakfast 2h before the study. All experiments 
were carried out in the morning in a temperature- 
controlled observation room.
During the study the subjects remained supine, 
with the lower body sealed at the iliac crests in an 
airtight Plexiglass™ box. The LBNP applied was 
recorded by a manometer connected to the inside of 
the box.
After local anaesthesia using lidocaine, a cannula 
was inserted percutaneously into a brachial artery, 
for monitoring arterial blood pressure and heart 
rate (Hewlett Packard, Böblingen, Germany) and 
for drawing arterial blood samples. In the same 
arm, a cannula was inserted for collecting venous 
blood. Another venous cannula was inserted in the 
contralateral arm, for infusion of [ 3H]NA or
[3H]AD.
Forearm blood flow (FBF) was measured using 
venous occlusion strain-gauge plethysmography 
[10] on the forearm contralateral to that used for
[3H]NA infusion and it was positioned 10 cm above 
the mid-thoracic level. Measurements of FBF were 
obtained after exclusion of the hand circulation by 
inflating a wrist cuff to 100 mmHg above systolic 
blood pressure for at least lm in [11].
After instrumentation, the subjects rested for 
30 min. During the last 3 min, baseline recordings of 
blood pressure, heart rate and FBF (nine flow 
curves) were obtained. Blood pressure was recorded 
simultaneously with each FBF measurement. Ther­
eafter, arterial and venous blood samples were 
drawn simultaneously for determinations of plasma 
catecholamines. Six subjects were infused with the 
radiotracer [ 3H]NA (L-2,5,6-[3H]NA) (specific 
activity 30-60 Ci/mmol) and another six were 
infused with [ 3H]AD (L-iV-methyl-[3H]AD) (speci­
fic activity 55-85 Ci/mmol). An intravenous bolus of 
15/iCi/m2 (0.55MBq/m2) was administered, 
followed by a constant infusion of 0.35/¿Ci 
m in” ^ ' 2 (0.013 MBq min'"1 m -2) for 120min. In 
two subjects, [3H]NA and [ 3H]AD were infused 
simultaneously. The first LBNP application began 
30 min after the start of infusion of the radiotracers.
LBNP at —15mmHg was applied for 30min. 
Blood pressure, heart rate, FBF and blood samples 
were taken in sequence, beginning after 7, 17 and 
27 min of LBNP, so that the blood samples were 
drawn at 10, 20 and 30 min of LBNP. A 30-min rest 
period ensued, followed by another 30 min of LBNP 
at —40 mmHg. Blood pressure, pulse rate, FBF and 
blood samples were obtained at the same time 
points as during LBNP at —15 mmHg.
Materials
Tritiated NA and AD were obtained from Du 
Pont New England Nuclear (’s-Hertogenbosch, The 
Netherlands). The radionuclides were sterilized 
using a 0.22 /¿m filter and diluted in 0.9% NaCl 
containing acetic (0.2 mol/1) and ascorbic ( 1 mg/ml) 
acids. Aliquots of lO f id  of [3H]NA and [3H]AD 
were stored at — 80°C until used. Sterilization, 
dilution and aliquoting were carried out under 
nitrogen. Just before use, an aliquot was diluted in 
0.9% NaCl. The syringe containing the radiotracer 
was weighed just before and just after the infusion, 
in order to verify the infusion rate. Samples of the 
infusâtes were taken at the end of the infusion and 
stored at — 80°C.
Analytical methods
Blood samples were collected in chilled tubes 
containing glutathione (0.2 mol/1) and EGTA < 
(0.25 mol/1). The tubes were centrifuged at 4°C and 
the plasma was separated and stored at — 20°C. 
Assays of samples and infusâtes were carried out 
within 2 months of each study.
Plasma samples were assayed for concentrations 
of AD and NA using HPLC with fluorimetrie
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Table I. Haemodynamic variables before (basal) and during LBNP at — 15 and —40mm Hg. Values are expressed as 
means + SEM. Statistical significance (Wilcoxon signed-rank test): *P <0.05.
Basal LBNP (-15 mmHg) Basal LBNP ( — 40mmHg)
[3H]NA infusion (n«8)
Mean arterial pressure (mmHg) 90 + 3 89 + 3 92 + 2 93 + 3
Pulse pressure (mmHg) 66±3 63 ±4 62 ±3 55 ±3*
Heart rate (beats/min) 58±4 57 ±4 56±4 63 ±4*
FBF (mlmin“ 1100ml-1) 1.81 ±0,27 1.38 + 0.22* 1.85 ± 0.24 1.00 ± 0.22*
FVR (arbitrary units) 64±3 80 + 12* 57 + 8 122 ±19*
[JH]AD infusion (n ~8)
Mean arterial pressure (mmHg) 81 ±2 83 ±2 88 ±2 90 ± 2
Pulse pressure (mmHg) 58 ± 3 57 ±3m m 53 ±5 47 ±6*
Heart rate (beats/min) 54±3 53 + 2 53 ±2 61 ±3*
FBF (mlmin-1100ml“ *) 1,59 ±0,23 l.l 1 ±0.20* 1.49 ± 0.25 0.90 ± 0.23*
FVR (arbitrary units) 59 ± 8 90± 14* 74± 12 147 ±32*
detection after precolumn derivatization with the 
fluorescent agent 1,2-diphenylethylenediamine [12]. 
A Gilson fraction collector (Model 201-202), which 
was connected to an automatic sample injector 
(Wisp 710B), was used for collecting [ 3H]NA and 
[ 3H]AD into scintillation vials, according to the 
retention times of NA and AD standards.
Data analysis
Forearm vascular resistance (FVR) was calculated 
by dividing mean arterial blood pressure by FBF 
and was expressed in resistance units.
The clearance of NA from arterial plasma, CL, 
was calculated from the infusion rate of [3H]NA 
and the steady-state arterial plasma concentration of 
the tracer, [3H]NAa:
CL (1/min) =  infusion rate (d.p.m./min)/[3H]NA0
(d.p.m./l)
‘Total body’ NA spillover, the estimated rate of 
appearance of endogenous NA in arterial plasma, 
representing generalized sympathetic nerve activity, 
was calculated from the arterial plasma NA con­
centration (NAJ and the arterial steady-state clear­
ance of NA, according to the equation:
Total body NA spillover (nmol/min)
= NA„ (nmol/1) x CL (1/min)
Analogously, NA spillover in the forearm was esti­
mated from:
Forearm spillover (pmol min - 1 100 ml
[FPF x NAa x fNA] +  [F P F  x (NA NAJ]
where fNA =  ([3H]NA„ -  [ 3H]N Av )/[ JH]NAfl, the 
fractional extraction of the tracer in the forearm; 
FPF is the forearm plasma flow, in units of 
ml min“ 1100ml“ *, calculated from the FBF and 
haematocrit; and [ 3H]NAV is the venous plasma 
concentration of [3H]NA.
The removal of NA in the forearm was calculated 
from:
3 3
Forearm removal (pmol min 
= FPF x NAa x fNA
i 100 ml
The clearance of AD from arterial plasma and the 
estimated rate of appearance of endogenous AD in 
arterial plasma were calculated according to the 
same formulas.
Results are expressed as means+ SEM. For each 
variable, the mean of the three observations at the 
three time points during each LBNP was calculated. 
Within each group, the effects of LBNP on each 
variable were tested by the Wilcoxon signed-rank 
test. This test was also used for testing differences 
between LBNP at —15 and at —40mmHg. A P- 
value below 0.05 defined statistical significance.
RESULTS
Baseline measurements.
At baseline, total body spillover of NA 
(2.81 ±0.34 nmol/min) was about seven to eight 
times higher than that of AD (0.36 ±0.05 nmol/min). 
Clearances of NA and AD from arterial plasma 
were similar (3.17 + 0.34 and 2.84±0.14l/min).
LBNP at — ISmmHg
Mean arterial blood pressure, pulse pressure and 
heart rate did not change during LBNP at 
— ISmmHg (Table 1). FBF decreased significantly 
by about 30% and FVR increased by about 25-50%.
The increase in venous plasma NA was larger 
than that of arterial plasma NA during LBNP at 
15 mmHg, while the increase in venous plasma 
AD was smaller than that of arterial plasma AD 
(Table 2). The total body spillover of NA did not 
increase during LBNP at —15 mmHg (Fig. 1), wher­
eas the forearm spillover of NA increased in seven 
out of eight subjects, from 0.63 ±0.16 to 0.94±  
0.23 pmol m in“ 1 100 m l” 1 (P<0.05) (Fig. 1). The
clearance of NA from arterial plasma tended to 
decrease (PcO.lO). The removal of NA from
forearm did not change during LBNP at
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Table 2. Plasma concentrations of NA and AD, total body and forearm spillover and removal of NA before (basal) and 
during LBNP at —15 and — 40mmHg. Values are expressed as means±SEM. Statistical significance {Wilcoxon signed-rank test): 
*P<0,05.
Basal LBNP
( — IS mmHg)
Basal LBNP
( — 40 mmHg)
[3H]NA infusion (n = 8)
Venous NA (nmol/l) 0,90 +  0.10 1.44 ±  0.20* 1.13 ±0.19 2.60 ± 0.30*
Arterial NA (nmol/l) 0.90+0,06 I.I0+ 0.I0* 1.01 ±0.12 1.88 ± 0.07*
Total body NA spillover 2.81 +0.34 2.78 ±0.30 3.00 ±0.42 3.89 ±0.30*
(nmol/min)
NA clearance (l/mln) 3.17 + 0.34 2.57 ±0.19 3.12± 0.39 2.08 ±0.15*
Forearm NA spillover 0.63 + 0,16«iWWW 0.94 ±0.23* 0.73 ±0.19 1.32 ±0.36*
(pmolmin^1100ml ')
Forearm NA removal 0.62 ±0.11 0.67 ±0.13 0.70 ±0.15 0.91 ±0,24
(pmol min” 1100 ml""1) 
[3H]adrenaline infusion (n = 8)
Venous AD (nmol/l) 0.06 + 0.01 0.08 ±0.01* 0.07 ±0.01«mW* 0.14 ±0,02*
Arterial AD (nmol/l) 0.13 + 0,02 0.18 ±  0.02* 0.19 ±0.02 0.34 ± 0.03*
Total body AD spillover 0,36 + 0.05 0,48 ±  0.07*wipJnM 0.50 ± 0.07 0.72 ± 0.08*
(nmol/min)
AD clearance (1/min) 2.84 + 0.14 2.63 ±0,17 2.51 ±0.18 2.07 ±0.16*
Forearm AD removal 0.07 + 0.01 0.07 ±0,01 0.10 ±  0.02 0.11 ±0.03
(pmol min 1100ml ')
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Fig. I. Total body NA spillover and forearm NA spillover before 
and in response to LBNP at — 15 and — 40mmHg. NS, not
significant.
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Fig. 2. Total body AD spillover before and in response to LBNP at 
— 15 and —40mmHg.
15 mmHg (Table 2). The fractional extraction of 
NA increased slightly from 0.64 ±0.04 to 0.73 ±0,03 
(P<0.05).
The total body spillover of AD increased by
about 30% during LBNP at 15 mmHg, from
0.36 ±0,05 to 0.48 ±0.07 nmol/min (Table 2), The 
individual responses of total body spillover of AD 
are shown in Fig. 2. The clearance of AD from 
arterial plasma and the removal of AD from the
forearm did not
15 mmHg (Table 2).
change during LBNP a t
LBNP at —40mmHg
Mean arterial blood pressure did not change 
significantly during LBNP at - 4 0 mmHg but pulse 
pressure decreased and heart rate increased signifi-
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P =  0,09 P < 0.05
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cantly in both groups (Table 1). FBF decreased 
significantly by about 40-50% and the FVR
increased by about 100%.
The increase in venous plasma NA was larger 
than that of arterial plasma NA during LBNP at 
40 mmHg (Table 2). In contrast to LBNP at 
15 mmHg, the total body spillover of NA 
increased by about 30% during LBNP at 
40 mmHg, while the forearm spillover of NA 
increased by about 80% from 0.73 +  0.19 to 1.32 + 
0.36 pmol min ~1 100 m l-1 (Fig. 1). Figure 1 shows 
that the forearm spillover of NA increased in seven 
out of eight subjects. The clearance of NA from 
arterial plasma decreased significantly while the 
removal of NA from the forearm did not change 
significantly during LBNP at —40 mmHg (Table 2). 
The fractional extraction of NA increased slightly 
from 0.62 + 0.05 to 0.76 +  0.03 (P<0.05) during 
LBNP at —40mmHg.
The total body spillover of AD increased by 
about 50% in all subjects during LBNP at 
40 mmHg (Table 2 and Fig. 2). The clearance of 
AD from arterial plasma decreased while removal of 
AD from the forearm remained unchanged (Table 
2).
Comparison of LBNP at —15 and —40mmHg
Comparison of the responses during LBNP at 
— 15 and —40 mmHg was made for the variables 
whose values changed during both LBNP periods. 
The increase in FVR was larger during LBNP at 
40 than at — 15mmHg (P<0.05) (Table 1). The 
increments in venous and arterial plasma NA and 
AD were also significantly larger during LBNP at 
40 than at —15 mmHg (Table 2). The increase in 
forearm spillover of NA
40 mmHg (0.59+ 0.24 pmol min
at 15 mmHg (0.31+0.13 pmol min
tended to be larger at
1 100ml '
1100ml
than
i .
lover of AD was larger during LBNP at
40 mmHg (0.22 + 0.04 nmol/min) than at
15 mmHg (0.12 + 0.03 nmol/min; P <  0.05, Fig. 3).
DISCUSSION
The main new findings of this study were: (i) 
low-intensity LBNP increased forearm NA spillover 
and total body AD spillover without affecting total 
body NA spillover; (ii) high-intensity LBNP 
increased total body NA spillover; (iii) LBNP eli­
cited intensity-related increments in total body spil­
lover of AD and decreases in plasma clearances of 
NA and AD.
Zoller et al. [2] and Johnson et al. [31 demon-
l a *  « * •  Im* mm
strated that a LBNP of less than —20 mmHg 
selectively deactivates cardiopulmonary barorecep­
tors. At negative pressures exceeding —20 mmHg, 
there is additional deactivation of arterial baro­
receptors. Our data are in agreement with selective 
deactivation of cardiopulmonary baroreceptors 
during low-intensity LBNP ( — 15 mmHg), since we 
found no increase in heart rate or a decrease in 
pulse pressure in response to this stimulus. During 
LBNP at —40 mmHg, heart rate increased and 
pulse pressure decreased. At this stage, it is imposs­
ible to examine arterial baroreceptors separately 
from cardiopulmonary baroreceptors with LBNP 
since arterial baroreceptor deactivation cannot be 
attained without simultaneous perturbation of the 
cardiopulmonary baroreceptors. Two other factors 
impede an examination of the arterial baroreceptors 
separately. First, the stronger intensity of LBNP at 
40 mmHg does not only cause a concurrent deac­
tivation of arterial baroreceptors but probably also 
elicits a gradually stronger deactivation of cardio­
pulmonary baroreceptors. Second, there is a func­
tional interaction between arterial and cardiopul­
monary baroreceptors that does not allow
P = 0.09, Fig. 3). The increment in total body spil-
assessment of effects of arterial baroreceptor deacti­
vation by subtracting the effects of unloading of 
cardiopulmonary baroreceptors from that of simul­
taneous deactivation of arterial and cardiopulmon­
ary baroreceptors.
During low-intensity LBNP, there was an 
increase in forearm NA spillover but not in total 
body NA spillover. This not only confirms that 
cardiopulmonary baroreceptors play an important 
role in reflexive regulation of FBF but also indicates 
the regionalization of sympathoneuronal responses 
to this stressor. In contrast, total body spillover of 
NA increased during concomitant deactivation of 
cardiopulmonary and arterial baroreceptors, sug­
gesting more diffuse increases in sympathetic nerve 
outflows. Measurements of total body spillover of 
NA during orthostasis may therefore fail to detect 
regional sympathoneuronal responses. Differentiated 
sympathoneuronal response patterns have also been 
demonstrated for several other stressors.
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The plasma clearance of NA tended to decrease 
during cardiopulmonary baroreceptor deactivation 
and decreased further during simultaneous deactiva­
tion of arterial and cardiopulmonary baroreceptors. 
These decreases in plasma NA clearance probably 
resulted from decreases in cardiac output and 
splanchnic blood flow, as has been demonstrated 
during cardiopulmonary and arterial baroreceptor 
deactivation [13, 14].
Apart from sympathoneural activation during 
LBNP, we also found small but significant eleva­
tions in venous and arterial AD levels. The 
increments were larger during high-intensity LBNP 
than during low-intensity LBNP. Increments in 
plasma AD levels during low-intensity LBNP are in 
agreement with a previous study [8], Since we 
found no decrease in the clearance of AD and an 
increase in total body spillover of AD, the 
increments in plasma AD levels during low-intensity 
LBNP probably result from increased adreno­
medullary secretion. During combined deactivation 
of cardiopulmonary and arterial baroreceptors, 
there was a further increase in adrenomedullary 
secretion of AD, but now the decreased clearance of 
AD contributed to the larger increment in plasma 
AD levels during high-intensity LBNP.
LBNP at —45 to —50 mmHg is equivalent to 
head-up tilt to 90°, with respect to the amount of 
blood translocated. As shown previously, plasma 
NA and AD levels nearly double during orthostasis, 
and this is in agreement with the plasma catechola­
mine responses during LBNP at —40mmHg in the 
present study. These increments in plasma catecho­
lamine levels result from both increased arterial NA 
spillover and decreased plasma NA clearance [15]. 
In the present study, using LBNP at —40mmHg, 
responses of spillover and clearance were qualitati­
vely similar to those reported previously for head- 
up tilt.
LBNP induced a vasoconstrictor response in the 
forearm that was largest when both types of barore­
ceptors were deactivated simultaneously during 
high-intensity LBNP. This is in agreement with the 
further increase in forearm NA spillover during 
high-intensity LBNP. The larger responses of FVR 
and forearm NA spillover during high-intensity 
LBNP can be explained by either a stronger deacti­
vation of cardiopulmonary baroreceptors, or by the 
concurrent deactivation of arterial baroreceptors or 
both. Since there must be arterial baroreceptor 
deactivation during high-intensity LBNP [2, 3], our 
data indicate that arterial baroreceptors are proba­
bly as important for baroreflex control of the fore­
arm skeletal muscle circulation as cardiopulmonary 
baroreceptors. This conclusion is supported by the 
findings of microneurographic studies, showing that 
sympathetic nerve traffic responses were larger 
during deactivation of arterial baroreceptors than 
during deactivation of cardiopulmonary barorecep­
tors [6, 16]. Previous studies have suggested that 
cardiopulmonary baroreceptors play a major role in
the reflex control of the skeletal muscle circulation
[17].
The contribution of the skin to the FBF and thus 
to the forearm NA spillover should be considered. 
Some but not all previous studies showed that 
LBNP produced graded vasoconstriction of the skin 
vessels, thus contributing to the forearm vasocon­
strictor response [7, 18]. Assuming that sympathetic 
nerve traffic to the skin is also increased during 
LBNP, the increase in forearm NA spillover may 
overestimate the increase in muscle sympathoneural 
activity; however, if the increments in NA spillover 
from the skin and the muscles were proportionally 
the same at — 15 and at — 40 mmHg, then the 
conclusion that arterial baroreceptors are important 
for reflex regulation of skeletal muscle circulation 
would be still valid.
In conclusion, the data of this study indicate that 
selective deactivation of cardiopulmonary baro­
receptors during low-intensity LBNP increases NA 
release in the forearm and AD release by the 
adrenals. Concurrent deactivation of arterial barore­
ceptors during high-intensity LBNP produces 
further increases in forearm vasoconstriction and 
NA spillover, with increases also in total body NA 
and AD spillover and decreases in clearances of NA 
and AD.
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